| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Disc Medicine, Inc. | Director | Common Stock | 186,541 | $10,093,734 | $54.11 | 24 Mar 2025 | Indirect |
| Shattuck Labs, Inc. | Director | Common Stock | 1,051,021 | $911,970 | $0.8677 | 25 Aug 2025 | Indirect |
| Shattuck Labs, Inc. | Director | Common Warrants (right to buy) | 3,073,298 | 25 Aug 2025 | Indirect | ||
| Shattuck Labs, Inc. | Director | Pre-Funded Warrants (right to buy) | 2,022,277 | 25 Aug 2025 | Indirect | ||
| Shattuck Labs, Inc. | Director | Stock Option (Right to Buy) | 66,300 | 28 Aug 2025 | Direct | ||
| Disc Medicine, Inc. | Director | Stock Option (Right to Buy) | 10,000 | 11 Jun 2025 | Direct | ||
| Sierra Oncology, Inc. | Director, 10%+ Owner | Common Stock | 0 | $55.00 | 01 Jul 2022 | Indirect | |
| Sierra Oncology, Inc. | Director, 10%+ Owner | Series A Warrants | 0 | 01 Jul 2022 | Indirect | ||
| Sierra Oncology, Inc. | Director, 10%+ Owner | Series B Warrants | 0 | 26 Jan 2022 | Indirect | ||
| Sierra Oncology, Inc. | Director, 10%+ Owner | Stock Option (right to buy) | 0 | 01 Jul 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| STTK | Shattuck Labs, Inc. | 28 Aug 2025 | 1 | $0 | 4 | Director | 02 Sep 2025, 06:35 |
| STTK | Shattuck Labs, Inc. | 25 Aug 2025 | 6 | +$5,471,826 | 4 | Director | 02 Sep 2025, 21:50 |
| STTK | Shattuck Labs, Inc. | 25 Aug 2025 | 0 | $0 | 3 | Director | 02 Sep 2025, 06:30 |
| IRON | Disc Medicine, Inc. | 11 Jun 2025 | 1 | $0 | 4 | Director | 13 Jun 2025, 17:10 |
| IRON | Disc Medicine, Inc. | 24 Mar 2025 | 3 | -$310,483 | 4 | Director | 26 Mar 2025, 19:08 |
| IRON | Disc Medicine, Inc. | 19 Mar 2025 | 9 | -$2,831,987 | 4 | Director | 21 Mar 2025, 20:03 |
| IRON | Disc Medicine, Inc. | 10 Mar 2025 | 15 | -$16,965,596 | 4 | Director | 12 Mar 2025, 21:36 |
| IRON | Disc Medicine, Inc. | 17 Jun 2024 | 3 | +$3,000,024 | 4 | Director | 20 Jun 2024, 17:27 |
| IRON | Disc Medicine, Inc. | 12 Jun 2024 | 1 | $0 | 4 | Director | 14 Jun 2024, 16:15 |
| IRON | Disc Medicine, Inc. | 18 Dec 2023 | 3 | -$36,618 | 4 | Director | 20 Dec 2023, 18:16 |
| IRON | Disc Medicine, Inc. | 14 Dec 2023 | 3 | -$24,584,100 | 4 | Director | 15 Dec 2023, 18:09 |
| IRON | Disc Medicine, Inc. | 12 Dec 2023 | 8 | -$7,902,266 | 4 | Director | 14 Dec 2023, 17:40 |
| IRON | Disc Medicine, Inc. | 09 Jun 2023 | 1 | $0 | 4 | Director, 10%+ Owner | 09 Jun 2023, 18:15 |
| IRON | Disc Medicine, Inc. | 15 Feb 2023 | 3 | +$2,500,008 | 4 | Director, 10%+ Owner | 17 Feb 2023, 15:48 |
| IRON | Disc Medicine, Inc. | 29 Dec 2022 | 1 | $0 | 4 | Director | 03 Jan 2023, 20:23 |
| IRON | Disc Medicine, Inc. | 29 Dec 2022 | 0 | $0 | 3 | Director, 10%+ Owner | 03 Jan 2023, 20:19 |
| /report/000120919122040281-ashiya-mona-2022-07-01 | Sierra Oncology, Inc. | 01 Jul 2022 | 9 | -$108,062,350 | 4 | Director, 10%+ Owner | 01 Jul 2022, 16:46 |
| /report/000120919122005512-ashiya-mona-2022-01-26 | Sierra Oncology, Inc. | 26 Jan 2022 | 6 | +$6,434,340 | 4 | Director, 10%+ Owner | 28 Jan 2022, 20:23 |
| /report/000120919121039091-ashiya-mona-2021-06-08 | Sierra Oncology, Inc. | 08 Jun 2021 | 1 | $0 | 4 | Director, 10%+ Owner | 09 Jun 2021, 10:36 |